Ventio has been invited to present its findings to clinicians and researchers working on rare diseases Neurodegenerescence with Brain Iron Accumulation (NBIA). You can find the announcement for this symposium and the program here! Friday, june 5th 8h45 – 9h15 …
Following last week’s “Favorite” award at TDH2026, the momentum continues at Ventio! 🙏 We are thrilled to have won the Disruptive Innovation Award at the CIC Start Innovation Awards! 🎉 Thank you to the jury for their support! We accept …
We are honoured and proud to have been awarded the “Jury’s choice” prize last Thursday at the Hypergrowth Awards. 🙏 This recognition means a great deal to us and serves as a tribute to the hard work, dedication and vision of …
Our mission: to better understand, diagnose earlier, and accurately monitor neurodegenerative diseases by tracking brain iron. To achieve this mission, we have taken three major steps: ✅ A partnership to strengthen understanding of these diseasesLaunch of the QSM for Alzheimer’s Disease …
Committed to a quality approach involving information security management, Ventio has decided to follow the ISO 27001 standard, considered to be the benchmark in this field. Noémie Vang is a certified ‘Lead Implementer’, enabling the formal implementation of this standard …
Samira joins the Ventio team as a research scientist! Samira, You joined the Ventio team a few weeks ago as a research scientist. Welcome! Can you introduce yourself in a few words and tell us more about your academic and …
Potential Indications – Haemochromatosis Discover a potential indication of advanced technology of magnetic susceptibility. Dr ROCHE Stéphane Primary haemochromatosis, which is genetic in origin, is a dysregulation of the absorption and recycling of iron in the body. These dysregulations lead …
Potential Indications – Neurodegeneration with brain iron accumulation Discover a potential indication of QSMetric™ technology. Dr ROCHE Stéphane Neurodegeneration due to intracerebral iron accumulation (NBIA) is a group of genetic diseases characterised by a constant accumulation of iron in specific …
Potential Indications – Huntington disease Discover a potential indication of advanced technology of magnetic susceptibility Dr ROCHE Stéphane Huntington’s disease is a rare, hereditary neurodegenerative disorder. There is an adult form and an even rarer juvenile form. It is characterized …
Potential Indications – Traumatic brain injury Discover a potential indication of advanced technology of magnetic susceptibility. Dr ROCHE Stéphane Traumatic brain injuries are caused by impacts of varying intensity to the skull. The severity of the trauma ranges from minor …
Potential Indications – Multiple sclerosis Discover a potential indication of advanced technology of magnetic susceptibility. Dr ROCHE Stéphane Multiple sclerosis is an autoimmune disease linked to the presence of white matter lesions associated with chronic inflammation leading to demyelination. Active …
Potential Indications – Vascular dementia Discover a potential indication of advanced technology of magnetic susceptibility. Dr ROCHE Stéphane Vascular dementia is a neurodegenerative disease with multiple aetiologies. Damage to cerebral nervous tissue may be due to ischaemic lesions involving small …
QSMetric Potential Indications – Parkinson disease Discover a potential indication of QSMetric™ technology. Dr ROCHE Stéphane Parkinson’s disease is a neurodegenerative disorder caused by the formation of a-synuclein protein aggregates in neurons and their death. Associated with this aggregation is …
Feasibility and Potential of Quantitative Susceptibility Mapping in Neurodegeneration with Brain Iron Accumulation (NBIA) at Clinical Magnetic Field European Society for Magnetic Resonance in Medicine and Biology, 41st annual scientific meeting; MR to the limits and beyond, Oct 2025, Marseille, …
Quantitative Susceptibility Mapping of the Cervical Spinal Cord at 3T and Application to Multiple Sclerosis NMR in Biomedicine, 2026, 39 (6) Benjamin Streichenberger (1) , Mathieu Santin (2) , Ludovic de Rochefort (3) , Quentin Duché (4) , Catherine Guillemot (5), Samira Mchinda (3) , Stéphane Roche (3) , Anne Kerbrat (1, 6) , Elise Bannier (1, …
Iron load in the normal aging brain measured with QSM and R2* at 7T: findings of the SENIOR cohort Miguel Guevara, Stéphane Roche, Vincent Brochard, Davy Cam , Jacques Badagbon , Yann Leprince, Michel Bottlaender, Yann Cointepas, Jean-François Mangin, Ludovic de Rochefort , Alexandre Vignaud Frontiers in Neuroimaging, Sec. Neuroimaging …
Reusing health data to develop value-added tools for radiology Stéphane Roche, Miguel Guevara, Ludovic de Rochefort , Alexandre Vignaud Journées Francophones de Radiologie, 4-7 octobre, Paris, France Abstract : Objectif Health data, particularly imaging data, is at the heart of the healthcare system …
Dr. Stephane ROCHE, PhD, Dr. Ludovic de ROCHEFORT, PhD; Novembre 2022 Definition: QSM (Quantitative Susceptibility Mapping) is an advanced biomedical imaging technique for research, based on Magnetic Resonance Imaging (MRI) 1,2. The QSM technology identifies the position and intensity of …
QSM4SENIOR: Quantitative susceptibility mapping in the aging of the healthy brain. Miguel Guevara1,2, Davy Cam3, Jacques Badagbon3, Michel Bottlaender2, Yann Cointepas1,2, Jean-François Mangin1,2, Ludovic de Rochefort3 and Alexandre Vignaud1,2 Joint Workshop on MR phase, magnetic susceptibility and electrical properties mapping, …
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations Yuto Uchida, Hirohito Kan, Keita Sakurai, Kenichi Oishi and Noriyuki Matsukawa Frontiers In Neuroscience, 5 august 2022 Alzheimer’s disease (AD) is the most common type of …
Phenotypic and genetic associations of quantitative magnetic susceptibility in UK Biobank brain imaging Chaoyue Wang, Aurea B. Martins-Bach, Fidel Alfaro-Almagro, Gwenaëlle Douaud, Johannes C. Klein, Alberto Llera, Cristiana Fiscone, Richard Bowtell, Lloyd T. Elliott, Stephen M. Smith, Benjamin C. Tendler …
Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process? Farzaneh Nikparast, Zohreh Ganji, Mohammad Danesh Doust, Reyhane Faraji & Hoda Zare Insights into Imaging volume 13, Article number: 74 (2022) The …
510(k) Premarket Notification Device Classification Name system, nuclear magnetic resonance imaging 510(k) Number K210415 Device name QSM software, QSMetric Applicant Medimagemetric LLC171 Floral AveJohnson City, NY 13790 Regulation Number 892.1000 Decision Date 07/22/2021
Accurate quantification of magnetic susceptibility in molecular mri Inventor: Yi Wang, Ludovic De Rochefort, Bryan Kressler, Tian LIU, Pascal Spincemaille
Imaging the aging brain: study design and baseline findings of the SENIOR cohort Alexa Haeger, Jean-François Mangin, Alexandre Vignaud, Cyril Poupon, Antoine Grigis, Fawzi Boumezbeur, Vincent Frouin, Jean-Robert Deverre, Marie Sarazin, Lucie Hertz-Pannier, Michel Bottlaender & the SENIOR team Alzheimer’s …
Optimisation théorique et expérimentale de la technique IRM du transfert d’aimantation inhomogène pour l’imagerie de la myéline : application à la sclérose en plaques Auteur : Samira Mchinda Direction : Guillaume Duhamel, Olivier Girard Type : Thèse de Doctorat Etablissement …
Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Site Reproducibility and Single-Site Robustness Pascal Spincemaille, Zhe Liu, Shun Zhang, Ilhami Kovanlikaya, Matteo Ippoliti, Marcus Makowski, Richard Watts, Ludovic de Rochefort, Vijay Venkatraman, Patricia Desmond, Mathieu D. Santin, Stéphane …
Clinical Integration of Quantitative Susceptibility Mapping Magnetic Resonance Imaging into Neurosurgical Practice S. Kathleen Bandt, Ludovic de Rochefort, Weiwei Chen, Alexey V. Dimov, Pascal Spincemaille, Brian H. Kopell, Ajay Gupta, Yi Wang World Neurosurgery, Volume 122, February 2019, Pages e10-e19 …
Decreased sAβPPβ, Aβ38, and Aβ40 Cerebrospinal Fluid Levels in Frontotemporal Dementia Gabelle, Audrey, Roche, Stéphane, Gény, Christian, Bennys, Karim, Labauge, Pierre, Tholance, Yannick, Quadrio, Isabelle, Tiers, Laurent, Gor, Baptiste, Boulanghien, Justine, Chaulet, Chloé, Vighetto, Alain, Croisile, Bernard, Krolak-Salmon, Pierre, Perret-Liaudet, …
Correlations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40 and 42 in human cerebrospinal fluid Audrey Gabelle, S. Roche, Christian Geny, Karim Bennys, Pierre Labauge, Yannick Tholance, Isabelle Quadrio, Laurent Tiers, Baptiste Gor, Chloé Chaulet, Alain Vighetto, …
Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Validation and application to brain imaging Ludovic de Rochefort, Tian Liu, Bryan Kressler, Jing Liu, Pascal Spincemaille, Vincent Lebon, Jianlin Wu, Yi Wang Magnetic Resonance in Medicine, 2010 The …
Preanalytical guidelines for clinical proteomics investigation of biological fluids S Lehmann, S. Roche, Y. Allory, A. Barthelaix, J.-L. Beaudeux, F. Berger, F. Betsou, J. Borg, A. Dupuy J. Garin, M. Quillard, G Lizard, K. Peoc’H, M. Riviere & P. Ducoroy …
Les marqueurs biologiques protéiques du liquide céphalorachidien : caractéristiques et implications cliniques dans les démences A Gabelle, S. Roche & S Lehmann Revue Neurologique, Volume 165, Issue 3, March 2009, Pages 213-222 Résumé : L’exactitude du diagnostic dans le champ …
Ventio participera au salon Vivatech, le grand rendez-vous de l’innovation et des start-up.
Infos pratiques :
Paris Expo Porte de Versailles
17-20 juin 2026
Stand CIC, Pavillon 7 Booth 2B28-005
Venez échanger avec notre équipe sur place.
